Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
Submitted by
admin
on January 5, 2016 - 11:20am
Source:
BioPharma Dive
News Tags:
Baxalta
Shire
M&A
immuno-oncology
Symphogen
R&D
Headline:
Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
Do Not Allow Advertisers to Use My Personal information
